Medicine guide

Baiama 40 mg/ml

As listed in the register: Baiama 40 mg/ml, solution injectable

40 mg/ml ·

  • Prescription only
  • Eyes and ears
Active substance
Afliberceptum
Made by
Horus Pharma Suisse SA

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

  • Dégénérescence maculaire liée à l'âge de la forme exsudative (humide) (DMLAe). Œdème maculaire secondaire à une occlusion de la veine centrale de la rétine (OVCR) et de branche veineuse rétinienne (OBVR). Œdème maculaire diabétique (OMD). Traitement de la néovascularisation choroïdienne sous-fovéale et juxtafovéale consécutive à une myopie pathologique (NVCm).

From the official label · 2026-09-30 · Swissmedic

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

European UnionNo exact match for this strength and form

SpainNo exact match for this strength and form

CanadaNo exact match for this strength and form

NetherlandsNo exact match for this strength and form

Details

Made byHorus Pharma Suisse SA
Active substanceAfliberceptum
Used inEyes and ears
Strength40 mg/ml
ClassificationS01LA05 · Eyes and ears
Dispensing (as stated by the register)Abgabekategorie B
Name in the registerBaiama 40 mg/ml, solution injectable
Packs1 Durchstechflasche(n)
Zulassungsnummer70292
Dosisstärke1

Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician

Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.